The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study

The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study

<p>Abstract</p> <p>Background</p> <p>Studies suggest that patients with metastases limited in number and destination organ benefit from metastasis-directed therapy. Stereotactic body radiotherapy (SBRT) is commonly used for metastasis directed therapy in this group. How...

Full description

Bibliographic Details
Main Authors: Solanki Abhishek A, Weichselbaum Ralph R, Appelbaum Daniel, Farrey Karl, Yenice Kamil M, Chmura Steven J, Salama Joseph K
Format: Article
Language:English
Published: BMC 2012-12-01
Series:Radiation Oncology
Subjects:
“Stereotactic body radiotherapy”
SBRT
oligometastasis
“PET response”
Online Access:http://www.ro-journal.com/content/7/1/216

Internet

http://www.ro-journal.com/content/7/1/216

Similar Items